The directed movement of an organelle to a specific location.

A process in which a ribosome is transported to, and/or maintained in, a specific location.

The directed movement of substances out of the nucleus.

The directed movement of a ribosomal large subunit from the nucleus into the cytoplasm.

Any process that modulates the frequency, rate or extent of octopamine signaling pathway.

Any process that stops, prevents, or reduces the frequency, rate or extent of octopamine or tyramine signaling pathway.

The chemical reactions and pathways involving argininosuccinate, 2-(N(omega)-arginino)succinate, an intermediate in the ornithine-urea cycle, where it is synthesized from citrulline and aspartate.

The chemical reactions and pathways involving dicarboxylic acids, any organic acid containing three carboxyl (COOH) groups or anions (COO-).

The sequence of reactions by which arginine is synthesized from ornithine, then cleaved to yield urea and regenerate ornithine. The overall reaction equation is NH3 + CO2 + aspartate + 3 ATP + 2 H2O = urea + fumarate + 2 ADP + 2 phosphate + AMP + diphosphate.

Any process that activates or increases the frequency, rate or extent of octopamine or tyramine signaling pathway.

Any process that activates or increases the frequency, rate or extent of G protein-coupled receptor signaling pathway activity.

OBSOLETE. The chemical reactions and pathways involving any of the intermediate compounds involved in the urea cycle, a cyclic metabolic pathway that converts waste nitrogen in the form of ammonium to urea.

Any process that modulates the frequency, rate or extent of tyramine signaling pathway.

Any process that stops, prevents, or reduces the frequency, rate or extent of tyramine signaling pathway.

OBSOLETE. Any process that activates or increases the frequency, rate or extent of regulation of secondary heart field cardioblast proliferation.

Any process that modulates the frequency, rate or extent of cell proliferation involved in heart morphogenesis.

Any process that activates or increases the frequency, rate or extent of tyramine signaling pathway.

Any signalling pathway that decreases or inhibits the activity of a cell cycle cyclin-dependent protein kinase to modulate the switch from G1 phase to S phase of the cell cycle.

OBSOLETE. (Was not defined before being made obsolete).